Search bioRxiv⌕ Search

Biology subjects

Mhawech-Fauceglia, P.

Publications and source records attributed to Mhawech-Fauceglia, P..

3 recordsLinked to original sources

ShapeUpLMD: An Automated Pipeline for Spatially Optimized Laser Microdissection in Multi-omic Tissue Profiling

Laser microdissection (LMD) enables enrichment of defined cellular populations from heterogeneous tissues, providing histologically-resolved molecular profiles with spatial resolution. However, the absence of standardized methods for generating optimized regions of interest (ROIs) limits reproducibility and scalability for spatial multi-omic workflows. To address this gap, we developed ShapeUpLMD, an open-source software tool and integrated workflow that automates the optimization of spatially defined ROIs for LMD, directly from digital pathology annotations. Fresh-frozen uterine serous carcinoma (USC) tumors (n = 11) were sectioned onto polyethylene naphthalate slides, scanned and subsequently annotated by an expert pathologist. Tumor and non-tumor ROIs were used to train tumor-specific classifiers in HALO (Indica Labs). Classified tumor or unbiased whole tissue ROIs were refined and optimized by ShapeUpLMD prior to automated collection on a Leica LMD7 microscope. Across the cohort, predicted tumor ROIs increased effective tumor purity by 86 {+/-} 6% relative to whole tissue while maintaining high spatial concordance between predicted and collected ROIs (accuracy = 0.9 {+/-} 0.05). Data-independent acquisition mass spectrometry quantified upwards of [~]6,500 proteins across spatially resolved ROIs, revealing regionally coherent clustering of adjacent tumor regions and abundance patterns consistent with tumor and non-tumor cell admixture in an unbiased spatial proteomic application. ShapeUpLMD provides an automated, reproducible, and scalable framework that bridges digital pathology with LMD enabling high-fidelity spatial enrichment for multi-omic analyses. This workflow increases throughput, reduces inter-operator variability, and supports standardized, regionally resolved tissue collection for spatial systems biology applications. The software is available at https://github.com/GYNCOE/ShapeUpLMD.

cancer biology↗

Deep Quantitative Proteomics Identifies Conserved Proteome Alterations in Low and High-Grade Serous Ovarian Cancers

BackgroundLow-grade serous ovarian carcinoma (LGSOC) is a rare and largely chemoresistant subtype of epithelial ovarian cancer. Unlike treatment for high-grade serous ovarian cancer (HGSOC), management options for LGSOC patients are limited, in part, due to a lack of deep molecular characterization of this disease. To address this limitation, we aimed to define highly conserved proteome alterations in LGSOC by performing deep quantitative proteomic analysis of tumors collected from LGSOC (n=12) and HGSOC (n=24) patients or normal fallopian tube tissues (n=12) and validating proteins within two independent proteomic datasets of LGSOC (n=25) and HGSOC (n=49) tumors. ResultsOur efforts identified 275 protein alterations conserved between LGSOC and HGSOC tumors that exhibit high quantitative correlation between discovery and validation cohorts (Spearman Rho [&ge;] 0.82, P < 1E-4). Conserved proteins elevated in LGSOC tumors were enriched for pathways regulating cell adhesion and defective cellular apoptosis signaling and candidates mapping as putative drug targets included 5-nucleotidase/ cluster of differentiation 73 (NT5E/CD73). We also identified MUC16 (CA125) as significantly elevated in LGSOC versus HGSOC tumors and confirmed this by immunohistochemistry analysis between three independent reviewers. We also find that MUC16 exhibits a more apical versus membrane-staining pattern in LGSOC tumors, suggesting unique regulation of MUC16 in this disease subtype. ConclusionOur efforts define highly conserved protein alterations distinguishing LGSOC from HGSOC tumors, including CD73, as well as the novel identification that MUC16 is elevated and exhibits more apical staining pattern in LGSOC tumor tissues. These findings deepen our molecular understanding of LGSOC and provide unique insights into highly conserved proteome alterations in LGSOC tumors.

cancer biology↗

Integrated Molecular Profiling Studies to Characterize the Cellular Origins of High-Grade Serous Ovarian Cancer

Historically, high-grade serous ovarian cancers (HGSOCs) were thought to arise from ovarian surface epithelial cells (OSECs) but recent data implicate fallopian tube secretory epithelial cells (FTSECs) as the major precursor. We performed transcriptomic and epigenomic profiling to characterize molecular similarities between OSECs, FTSECs and HGSOCs. Transcriptomic signatures of FTSECs were preserved in most HGSOCs reinforcing FTSECs as the predominant cell-of-origin; though an OSEC-like signature was associated with increased chemosensitivity (Padj = 0.03) and was enriched in proliferative-type tumors, suggesting a dualistic model for HGSOC origins. More super-enhancers (SEs) were shared between FTSECs and HGSOCs than between OSECS and HGSOCs (P < 2.2 x 10-16). SOX18, ELF3 and EHF transcription factors (TFs) coincided with HGSOC SEs and represent putative novel drivers of tumor development. Our integrative analyses support a predominantly fallopian origin for HGSOCs and indicate tumorigenesis may be driven by different TFs according to cell-of-origin.

cancer biology↗